CVE-2023-3840

NxFilter cross site scripting

Description

A vulnerability, which was classified as problematic, was found in NxFilter 4.3.2.5. This affects an unknown part of the file /report,daily.jsp?stime=2023%2F07%2F12&timeOption=yesterday&. The manipulation of the argument user leads to cross site scripting. It is possible to initiate the attack remotely. The associated identifier of this vulnerability is VDB-235191. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Category

3.5
CVSS
Severity: Low
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: n/a NxFilter
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.235191 third party advisory vdb entry permissions required technical description
https://vuldb.com/?ctiid.235191 signature third party advisory permissions required

Frequently Asked Questions

What is the severity of CVE-2023-3840?
CVE-2023-3840 has been scored as a low severity vulnerability.
How to fix CVE-2023-3840?
To fix CVE-2023-3840, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-3840 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-3840 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-3840?
CVE-2023-3840 affects n/a NxFilter.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.